Doug Jermasek, Exec Vice Head Of State, Corporate Method for Unicycive Rehabs, Inc. UNCY, was lately spoken with by Benzinga.
Unicycive is a biotechnology business concentrated on services for essential and also underserved kidney illness. The business presently has 2 crucial innovations in the advancement pipe.
UNI-494 functions mainly to aid the mitochondria in cells execute much better, which consequently might aid with Severe Kidney Injury (AKI). The business’s various other modern technology, Renazorb, is presently being created as an Investigatory New Medicine (IND). If accepted, the medication will certainly aid individuals dramatically lower their everyday tablet worry in the therapy of hyperphosphatemia.
View the complete meeting below:
Included image by Hal Gatewood on Unsplash
© 2023 Benzinga.com. Benzinga does not give financial investment recommendations. All legal rights booked.
